Ares-Serono interferon formulations
Company's interferon product Frone (human fibroblast interferon) received approval in Italy for marketing in cream, injectable and eye drop forms. Indications include genital herpes, keratoconjunctivitis and condylomata. Drug is already marketed in Israel in cream form; Phase III clinicals are underway in U.S. under a limited partnership between Serono and Braintree Research Associates
You may also be interested in...
Frank Zhang, co-founder and chair of the Hong Kong-listed Chinese biotech Genscript, parent of Nasdaq-listed cell therapy star, Legend Biotech, has been detained by Chinese authorities, along with four employees.
Tests used to detect cytomegalovirus in organ transplant patients may face an easier path to market under a proposed rule that the US Food and Drug Administration released on 18 September. See what the regulatory agency said about it here.
While neither party is likely to make any big policy changes this year, the action from both sides of the aisle indicates politicians still see going after pharma as a winning issue with voters even as polls show voters are focused elsewhere.